<?xml version='1.0' encoding='utf-8'?>
<document id="23896476"><sentence text="Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovir."><entity charOffset="101-110" id="DDI-PubMed.23896476.s1.e0" text="tenofovir" /></sentence><sentence text="A once-daily single-tablet antiretroviral regimen containing tenofovir (TFV) disoproxil fumarate, emtricitabine (FTC), elvitegravir (EVG), and cobicistat (COBI) is an approved combination for the treatment of patients infected with HIV"><entity charOffset="61-70" id="DDI-PubMed.23896476.s2.e0" text="tenofovir" /><entity charOffset="72-75" id="DDI-PubMed.23896476.s2.e1" text="TFV" /><entity charOffset="77-96" id="DDI-PubMed.23896476.s2.e2" text="disoproxil fumarate" /><entity charOffset="98-111" id="DDI-PubMed.23896476.s2.e3" text="emtricitabine" /><entity charOffset="113-116" id="DDI-PubMed.23896476.s2.e4" text="FTC" /><entity charOffset="119-131" id="DDI-PubMed.23896476.s2.e5" text="elvitegravir" /><entity charOffset="133-136" id="DDI-PubMed.23896476.s2.e6" text="EVG" /><entity charOffset="143-153" id="DDI-PubMed.23896476.s2.e7" text="cobicistat" /><entity charOffset="155-159" id="DDI-PubMed.23896476.s2.e8" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e0" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e1" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e2" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e3" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e4" e2="DDI-PubMed.23896476.s2.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e4" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e4" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e4" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e4" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e5" e2="DDI-PubMed.23896476.s2.e5" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e5" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e5" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e5" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e6" e2="DDI-PubMed.23896476.s2.e6" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e6" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e6" e2="DDI-PubMed.23896476.s2.e8" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e7" e2="DDI-PubMed.23896476.s2.e7" /><pair ddi="false" e1="DDI-PubMed.23896476.s2.e7" e2="DDI-PubMed.23896476.s2.e8" /></sentence><sentence text=" COBI and TFV have been reported to interact with distinct transporters in renal proximal tubules; while TFV is renally eliminated by a combination of glomerular filtration and tubular secretion via anion transporters OAT1, OAT3, and MRP4, COBI inhibits renal cation transporters, particularly MATE1, resulting in a measurable decrease in the tubular secretion of creatinine"><entity charOffset="364-374" id="DDI-PubMed.23896476.s3.e0" text="creatinine" /><entity charOffset="10-19" id="DDI-PubMed.23896476.s3.e1" text="TFV" /><entity charOffset="105-114" id="DDI-PubMed.23896476.s3.e2" text="TFV" /><entity charOffset="1-10" id="DDI-PubMed.23896476.s3.e3" text="COBI" /><entity charOffset="240-249" id="DDI-PubMed.23896476.s3.e4" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e3" e2="DDI-PubMed.23896476.s3.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e3" e2="DDI-PubMed.23896476.s3.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e3" e2="DDI-PubMed.23896476.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e3" e2="DDI-PubMed.23896476.s3.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e3" e2="DDI-PubMed.23896476.s3.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e1" e2="DDI-PubMed.23896476.s3.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e1" e2="DDI-PubMed.23896476.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e1" e2="DDI-PubMed.23896476.s3.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e1" e2="DDI-PubMed.23896476.s3.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e2" e2="DDI-PubMed.23896476.s3.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e2" e2="DDI-PubMed.23896476.s3.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e2" e2="DDI-PubMed.23896476.s3.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e4" e2="DDI-PubMed.23896476.s3.e4" /><pair ddi="false" e1="DDI-PubMed.23896476.s3.e4" e2="DDI-PubMed.23896476.s3.e0" /></sentence><sentence text=" To investigate the potential for a renal drug-drug interaction between TFV and COBI in vitro, the uptake of TFV in the presence and absence of COBI was determined in fresh human renal cortex tissue and in cells expressing the relevant renal transporters"><entity charOffset="72-75" id="DDI-PubMed.23896476.s4.e0" text="TFV" /><entity charOffset="109-112" id="DDI-PubMed.23896476.s4.e1" text="TFV" /><entity charOffset="80-83" id="DDI-PubMed.23896476.s4.e2" text="COBI" /><entity charOffset="144-147" id="DDI-PubMed.23896476.s4.e3" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e0" e2="DDI-PubMed.23896476.s4.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e0" e2="DDI-PubMed.23896476.s4.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e0" e2="DDI-PubMed.23896476.s4.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e0" e2="DDI-PubMed.23896476.s4.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e2" e2="DDI-PubMed.23896476.s4.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e2" e2="DDI-PubMed.23896476.s4.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e2" e2="DDI-PubMed.23896476.s4.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e1" e2="DDI-PubMed.23896476.s4.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s4.e1" e2="DDI-PubMed.23896476.s4.e3" /></sentence><sentence text=" At concentrations exceeding clinical protein-unbound plasma levels, COBI did not significantly inhibit the transport of TFV by the anion transporters OAT1, OAT3, and MRP4 (50% inhibitory concentrations [IC50s] of &gt;15, 6"><entity charOffset="121-124" id="DDI-PubMed.23896476.s5.e0" text="TFV" /><entity charOffset="69-72" id="DDI-PubMed.23896476.s5.e1" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s5.e1" e2="DDI-PubMed.23896476.s5.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s5.e1" e2="DDI-PubMed.23896476.s5.e0" /></sentence><sentence text="6, and 8" /><sentence text="5 μM, respectively)" /><sentence text=" Conversely, TFV had little or no effect on the cation transporters OCT2 and MATE1 (IC50 &gt; 100 μM)"><entity charOffset="13-16" id="DDI-PubMed.23896476.s8.e0" text="TFV" /></sentence><sentence text=" Consistent with studies using individual transporters, no increase in the accumulation of TFV in freshly isolated human renal cortex tissue or renal proximal tubule cells (RPTECs) was observed in the presence of COBI"><entity charOffset="91-93" id="DDI-PubMed.23896476.s9.e0" text="TFV" /><entity charOffset="213-215" id="DDI-PubMed.23896476.s9.e1" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s9.e0" e2="DDI-PubMed.23896476.s9.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s9.e0" e2="DDI-PubMed.23896476.s9.e1" /></sentence><sentence text=" Finally, COBI alone or in combination with FTC and EVG did not affect the sensitivity to TFV of cultured primary RPTECs or cells coexpressing OAT1 and MRP4"><entity charOffset="90-93" id="DDI-PubMed.23896476.s10.e0" text="TFV" /><entity charOffset="44-47" id="DDI-PubMed.23896476.s10.e1" text="FTC" /><entity charOffset="52-55" id="DDI-PubMed.23896476.s10.e2" text="EVG" /><entity charOffset="10-13" id="DDI-PubMed.23896476.s10.e3" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e3" e2="DDI-PubMed.23896476.s10.e3" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e3" e2="DDI-PubMed.23896476.s10.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e3" e2="DDI-PubMed.23896476.s10.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e3" e2="DDI-PubMed.23896476.s10.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e1" e2="DDI-PubMed.23896476.s10.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e1" e2="DDI-PubMed.23896476.s10.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e1" e2="DDI-PubMed.23896476.s10.e0" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e2" e2="DDI-PubMed.23896476.s10.e2" /><pair ddi="false" e1="DDI-PubMed.23896476.s10.e2" e2="DDI-PubMed.23896476.s10.e0" /></sentence><sentence text=" These results illustrate that COBI and TFV interact primarily with distinct renal transporters and indicate a low potential for pharmacokinetic renal drug-drug interaction"><entity charOffset="40-43" id="DDI-PubMed.23896476.s11.e0" text="TFV" /><entity charOffset="31-34" id="DDI-PubMed.23896476.s11.e1" text="COBI" /><pair ddi="false" e1="DDI-PubMed.23896476.s11.e1" e2="DDI-PubMed.23896476.s11.e1" /><pair ddi="false" e1="DDI-PubMed.23896476.s11.e1" e2="DDI-PubMed.23896476.s11.e0" /></sentence><sentence text=" " /></document>